EDITORIAL SECTIONS
RESEARCH & DEVELOPMENT
Adopting the Power of AI to Drug Development Projects
A tremendous amount of documentation is created throughout the clinical trial lifecycle
CLINICAL TRIALS
Real-world Evidence
Hearing the diagnosis from the doctor that your child has spinal muscular atrophy SMA
MANUFACTURING
Just in Time Manufacturing Creating more sustainable supply chains
Drug development has transformed immeasurably over the past decade Even before the Covid pandemic and the conflict in Ukraine
Information Technology
Challenges and Advantages of Using Artificial Intelligence in Pharma
Many advanced largescale AI initiatives still need to be proved successful in Pharma
KNOWLEDGE BANK
Interviews
Engineering the Future of Pneumococcal Conjugate Vaccines (PCV)
PhD, Chemical and Biotechnology, Savitribai Phule Pune University. Manager-Manufacturing, Inventprise Inc
Walmik Karbhari Gaikwad PhD is a seasoned biopharmaceutical expert with years in vaccine RD and manufacturing His PhD research pioneered costeffective processes for pneumococcal conjugate vaccines holds scholarly publications international patents and serves on editorial boards Based in Seattle currently works on cGMPcompliant process development and production at Inventprise Inc
Articles
Are We Ready to Ship Billions of COVID Vaccines Worldwide?
Theres no denying it has been a year of immense difficulty and disruptionMany now look forward to and the muchanticipated prospect of COVID vaccines as the gateway to global recovery Naturally as one of the the worlds leading logistics companies FedEx has an important role to play in vaccine shipment
Research Insights
Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections
There is disagreement about the level of asymptomatic severe acute respiratory syndrome coronavirus SARSCoV infection We conducted a living systematic review and metaanalysis to address three questions Amongst people who become infected with SARSCoV what proportion does not experience symptoms at all during their infection
Case Studies
Remarkable Regression Of A Giant Cell Tumor Of The Cervical Spinetreated Conservatively With Denosumab: A Case Study
Abstract This case study has been conducted to establish the fact that Denosumab can be used as an adjuvant therapy by which to avoid or reduce the risks and morbidity of surgical treatment in patients with spinal GCTs extending into the nearby tissues considering the adequate duration safety and lack of adverse events of this treatment even though further
Techno Trends
Breakthrough Gedatolisib Therapy Discovered for the Treatment of Metastatic Breast Cancer
Celcuity Inc discovered Gedatolisib new therapy for the treatment of HRHER Metastatic Breast Cancer Gedatolisib the firstinclass panPIKmTOR inhibitor is applicable for patients progressed with CDK therapy and a nonsteroidal aromatase inhibitor
White Papers
Cloud Computing in the Laboratory Informatics Solutions and Validation Approaches
In the modern business environment, a significant portion of work is conducted using computerized systems. Many solutions are used to complete tasks, including simple desktop programs like email and Microsoft Office to enterprise-wide, global systems like ERP (Enterprise Resource Planning), MES (Manufacturing Execution System), and LIMS
TOP ARTICLES
Integrated by Design
Venkat Reddy Sunkara is global head of Regulatory CMC at ICON. He has extensive expertise in managing Chemistry, Manufacturing, and Controls (CMC) aspects of regulatory submissions and post market compliance, supporting clients in achieving and maintaining adherence to global regulatory requirements. He brings over 20 years of pharmaceutical industry experience, including more than 10 years in CMO/CRO environments specializing in Regulatory CMC.
Nanoemulsion - A Promising Nanocarrier for Dermal Drug Delivery in Psoriasis
Sindhoor S M is currently working as an Assistant Professor in the Department of Pharmaceutics at Sri Adichunchanagiri College of Pharmacy, Mandya, Karnataka. His areas of specialisation include nanotechnology-based drug delivery system, lipid-based formulations, Topical delivery and gastroretentive in situ gel systems. He has published eight papers based on nanotechnology and lipid-based drug delivery system in peer reviewed indexed journals. Presently he is involved in the development of lipid-based delivery systems.
Marina Koland, is Professor and Head of the Department of Pharmaceutics at the NGSM Institute of Pharmaceutical Sciences, Nitte (Deemed to be University), Mangalore. Her area of specialisation in research is mucoadhesive and nanoparticulate drug delivery. She has published 50 research papers in peer reviewed journals, presented papers at 10 National and 3 International Conferences and worked on several Nitte University funded projects. She is currently working on solid lipid nanoparticles and micelles as drug carriers for targeting.
Metabolic Stability
Rajesh Sonti is working as an Assistant Professor since Feb 2020 in Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research (NIPER)-Hyderabad. He completed PhD from IISc, Bangalore and later worked as a post doc in University of Basel and EPFL-Lausanne for 6.5 years.
Venkata Rao Kaki is working as an Assistant Professor in Department of Chemical Sciences (medicinal chemistry/natural products),NIPER-Hyderabad. He completed PhD from Panjab university, Chandigarh. He has 4 years industrial and 8 years of academic experience.
Siva Nageswara Rao Gajulais pursuing PhD in Department of Pharmaceutical Analysis, NIPER-Hyderabad. He is working in the scientific areas:Drug Metabolism and Pharmacokinetics (DMPK), biomarkers and drug-drug interactions. He did M.S. (Pharm.) in department of pharmaceutical Analysisfrom NIPER-Ahmedabad.
Pursued M.S. (Pharm.), National Institute of Pharmaceutical Education and Research (NIPER)
Megha Sajakumar Pillai pursued M.S. (Pharm.) in department of pharmaceutical Analysis, NIPER-Hyderabad. She is currently pursuing PhD in NIPER-Ahmedabad.
Magnetic Nanoparticles and their Application Studies on Synthesis Characterisation
Prabhanjan S Giram qualified CSIR-NET AIR-81 in chemical sciences and received his Ph. D from National chemical laboratory, Pune. He Received Eudragit® 2018 Award of 1500 Euros from Evonik health care Germany. He also received newton Bhabha Fellowship from British council, UK and DBT, India. He has expertise in synthesis of biocompatible, biodegradable polymer with rationalised design of nanoformulation, nanofiber, semisolid dosage form such as ointment, creams, and gel.
Shubham R Musale has graduate in pharmacy from Savitribai Phule Pune University. He got fellowship for M.pharm from AICTE. The Thesis titled for M.pharm Design of In-expensive Collector for preparation Electrospun Nanofiber. He has 2 review publication and 1 Book Chapter.
Sushil Y Raut has over 12 years of teaching and research experience. He has more than 25 research and review publications. He filed 3 Indian patents and over 20 national as well as international presentations in his credits. He is recipient of international research mobility fellowship and other prestigious awards.
Tobacco-style Label Warning on Alcohol Products
Dr. M. Aamir Mirza is working as an Assistant Professor in the Department of Pharmaceutics, Jamia Hamdard, an NIRF Rank 1 institute and a NAAC ‘A+” grade deemed to be University. He has a multifaceted career portfolio adorned with both industry
press releasesRead more...
Takeda and Zuellig Pharma Announce Strategic Regional Collaboration to Expand Patient Access to Takeda's Innovative Medicines Across Southeast Asia
Takeda and Zuellig Pharma today announced a strategic regional collaboration to enhance sustainable patient access to innovative medicines and healthcare solutions across Malaysia Indonesia and the Philippines Effective December the collaboration
Delonix Bioworks and A*STAR Infectious Diseases Labs Announce Research Collaboration to Advance Novel Engineered OMV Vaccine Candidates Against Klebsiella pneumoniae
Delonix Bioworks a clinicalstage biotechnology company pioneering nextgeneration outer membrane vesicle OMV vaccines today announced that it has entered into a Research Collaboration Agreement with ASTAR Infectious Diseases
Lonza and CMS Sign License Agreement for NeuroPortal™ TfR1 Blood-Brain Barrier Technology
Lonza and China Medical System Holdings Limited CMS announced today a global exclusive license agreement for the use of Lonzas NeuroPortal transferrin receptor TfR bloodbrain barrier BBB technology in up to two products targeting
Sino Biological Launches 4RISE™ High-Throughput Wet-Lab Services to Accelerate AI-Driven Drug Discovery
AIdriven protein design is accelerating the discovery of novel protein binders but experimental validation remains essential to determine whether computational designs translate into meaningful target interactions To bridge this gap Sino Biological Inc Shenzhen Stock Exchange SZ a global leader in r...
Innovent Announces Positive CHMP Opinion, Recommending Zybrivo® (sintilimab) for First-Line Treatment of Non-squamous Non-Small Cell Lung Cancer
Innovent Biologics Inc Innovent HKEX a worldclass biopharmaceutical company that develops manufactures and commercializes highquality medicines for the treatment of oncologic autoimmune cardiovascular and metabolic
EventsRead more...
24 - 27
Nov 2026Pharmtech & Ingredients 2026
Crocus Expo, Pavilion 2, Mosco...
24 - 25
Nov 2026BioPharma Deals Conference 2026
Science Congress Center, Munic...
26 - 28
Nov 2026One Health Conference 2026
Thapar Institute of Engineerin...
01 - 03
Dec 2026Pharmaceutical Launch Excellence Summit
Novotel Amsterdam City, Nether...
01 - 03
Dec 202610th Antifibrotic Drug Development
Boston, MA at the Hotel Common...
02 - 04
Dec 2026Genome Informatics 2026
Wellcome Genome Campus, UK
03 - 04
Dec 2026Pharmacy and Pharmaceutical Conference
Madrid, Spain
03 - 04
Dec 2026Infectious and Rare Diseases
Paris, France
LATEST NEWSRead more...
OXB Partners with Aura Biosciences for Drug Manufacturing
OXB has confirmed a manufacturing and supply partnership with Aura Biosciences
GSK Receives Approval for Nelkarmi to Treat Advanced ALK-Positive Lung Cancer
GSK plc LSENYSE GSK has received accelerated approval from the US Food and Drug Administration FDA for Nelkarmi neladalkib a treatment for adults with locally advanced or metastatic anaplastic lymphoma kinase ALKpositive nonsmall cell lung cancer NSCLC
Erasca Enters into Collaboration with Bristol Myers Squibb to Evaluate Pancreatic Cancer Therapy
Erasca has entered into a clinical trial collaboration and supply agreement with Bristol Myers to evaluate the combination of ERAS and navlimetostat BMS an investigational PRMT inhibitor in patients with pancreatic cancer
OBI Pharma and Novartis Partner to Develop Next-Generation ADCs for Cancer Treatment
OBI Pharma has entered into a collaboration and licensing agreement with Novartis to develop nextgeneration antibodydrug conjugates ADCs using novel payloads and OBIs proprietary technology platforms
Merck to Acquire Rapid Micro Biosystems to Strengthen Automation in Pharmaceutical Quality Control
Merck has signed a definitive agreement to acquire Rapid Micro Biosystems a USbased provider of automated microbial qualitycontrol testing solutions for pharmaceutical manufacturing
Immuneering Enters into Collaboration with Astellas to Evaluate Combination Therapies for Pancreatic Cancer
Immuneering has entered into a clinical trial collaboration and supply agreement with Astellas Pharma to evaluate investigational combination therapies for patients with pancreatic cancer


